MyFinsight
Home
About
Contact
vrca: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, VRCA has $40,896K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
40,896
39,107
Total stockholders deficit
-17,040
-17,484
Total liabilities and stockholders deficit
40,896
39,107
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$3,586K
Inventory
$2,304K
Deferred r&d services,
current portion (note...
$1,959K
Collaboration receivable,
billed and unbilled
$282K
Accounts receivable
$7,047K
Cash and cash
equivalents
$21,097K
Other non-current
assets
$376K
Deferred r&d services,
non-current portion (note...
$2,354K
Finance lease
right-of-use asset
$1,050K
Operating lease
right-of-use asset
$616K
Property and equipment,
net
$225K
Total current assets
$36,275K
Total assets
$40,896K
Accumulated deficit
-$316,839K
Total liabilities and
stockholders deficit
$40,896K
Total stockholders
deficit
-$17,040K
Additional paid-in capital
$299,798K
Common stock, 0.0001
par value...
$1K
Total liabilities
$57,936K
Long term debt
$21,619K
R&d funding
liability (note 11)
$4,688K
Derivative liability
$1,762K
Finance lease liability
$629K
Operating lease liability
$330K
Total current
liabilities
$28,908K
Finance lease liability
$366K
Operating lease liability
$335K
Current portion of
long-term debt
$12,458K
Deferred revenue
$1,564K
Accrued expenses and
other current...
$12,600K
Accounts payable
$1,585K
Subscribe for Financial Insights
Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. (VRCA)